TABLE 2.
Metabolic parameters stratified by obesity class
| Subjects stratified by obesity class |
|||||
|---|---|---|---|---|---|
| All Patients | Class I | Class II | Class III | p value | |
| Number of Patients | 784 | 125 | 252 | 407 | |
| Male, % (N/T) | 45.2% (354/784) | 42.4% (53/125) | 40.5% (102/252) | 48.9% (199/407) | 0.086 |
| Race, % (N/T) | <0.001 | ||||
| White | 65.8% (516/784) | 51.2% (64/125) | 67.9% (171/252) | 69.0% (281/407) | |
| African American | 17.7% (139/748) | 20.0% (25/125) | 15.9% (40/252) | 18.3% (74/407) | |
| Hispanic | 7.9% (62/784) | 24.0% (30/125) | 7.1% (18/252) | 3.4% (14/407) | |
| Other | 8.6% (67/784) | 4.8% (6/125) | 9.1% (23/252) | 9.3% (38/407) | |
| County, % (N/T) | <0.001 | ||||
| Metro | 51.4% (399/777) | 77.0% (94/122) | 57.6% (144 /250) | 39.8% (161/405) | |
| Adjacent | 19.9% (155/777) | 11.5% (14/122) | 21.2% (53/250) | 21.7% (88/405) | |
| Rural | 28.7% (223/777) | 11.5% (14/122) | 21.2% (53/250) | 38.5% (156/405) | |
| Weight, kg ± SD | 79.9 ± 34.1 | 59.6 ± 21.5 | 71.0 ± 25.1 | 91.7 ± 37.4 | <0.001 |
| Height, cm ± SD | 149.0 ± 20.0 | 147.0 ± 18.5 | 148.8 ± 19.7 | 149.7 ± 20.7 | 0.424 |
| Age Group, % (N/T) | 0.722 | ||||
| 2–5 | 11.9% (93/784) | 9.6% (12/125) | 11.1% (28/252) | 13.0% (53/407) | |
| 6–9 | 26.7% (209/784) | 27.2% (34/125) | 25.0% (63/252) | 27.5% (112/407) | |
| ≥10 | 61.5% (482/784) | 63.2% (79/125) | 63.9% (161/252) | 59.5% (242/407) | |
| Abnormal ALT, % (N/T) | 51.5% (324/629) | 32.1% (36/112) | 46.9% (91/194) | 61.0% (197/323) | <0.001 |
| Dyslipidaemia, % (N/T) | 68.1% (453/665) | 60.3% (70/116) | 66.7% (140/210) | 71.7% (243/339) | 0.067 |
| Increased BP, % (N/T) | 31.2% (187/600) | 20.9% (18/86) | 25.1% (46/183) | 37.2% (123/331) | 0.002 |
| Diabetes risk, % (N/T) | 33.8% (233/690) | 28.8% (34/118) | 28.1% (62/221) | 39.0% (137/351) | 0.012 |
Note: % represents percent of the patients in the specific group, N represents the number of patients, where T represents total number of patients in that group. SD stands for standard deviation, ALT stands for alanine aminotransferase. Dyslipidaemia is defined as one or more of the following: increased total cholesterol, high LDL cholesterol, elevated triglycerides or low HDL cholesterol. Increased blood pressure was defined as having pre-hypertension or hypertension by auscultatory measurements. Diabetes risk was defined as having pre-diabetes or diabetes.